Sanket Koul, Shreya Nandi

All stories by Sanket Koul, Shreya Nandi

Weight Loss Drugs Sales Surge!
Rediff.com1 days ago

'The innovators have been able to more or less stay where they are, in terms of revenue...

Affordable housing may lose more ground as costs rise
Rediff.com5 May 2026

The ongoing West Asia conflict is expected to severely impact the supply of affordable...

Chinese API price surge tests India's pharma buffers amid West Asia crisis
Rediff.com2 May 2026

India's pharmaceutical industry is experiencing increased bulk drug prices,...

Canada first G7 nation to okay Dr Reddy's generic version of semaglutide
Rediff.com30 Apr 2026

Dr Reddy's Laboratories has received approval from Health Canada to sell a generic...

Pressure builds on developers to hike prices as costs rise
Rediff.com13 Apr 2026

Indian realty developers are contemplating price increases for ongoing and upcoming...

Indian HNIs maintain grip on Dubai luxury real estate despite West Asia tensions
Rediff.com6 Apr 2026

Ongoing geopolitical tensions in West Asia have slowed deal momentum in Dubai's luxury...

Noida International Airport: Property Prices Soar Along Yamuna Expressway
Rediff.com30 Mar 2026

The inauguration of Noida International Airport (NIA) is set to significantly increase...

Centre Cracks Down on GLP-1 Drug Misuse
Rediff.com25 Mar 2026

Inspections conducted across 49 entities including pharmacies, wholesalers, and clinics...

Semaglutide Ruling Sparks Generic Pharma Boom
Rediff.com24 Mar 2026

At the heart of this debate is Section 3(d) of the Patents Act, a safeguard designed to...

Reality check gets India on investors' realty list
Rediff.com23 Mar 2026

Escalating geopolitical tensions in West Asia are prompting investors with exposure to...

Weight Loss Drugs Set to Flood India
Rediff.com16 Mar 2026

While the introduction of branded generics is likely to accelerate volumes for GLP-1...

US Business Schools Eye India Partnerships
Rediff.com12 Mar 2026

The outreach comes amid a drop in Indian student enrolments in management programmes at...

Terms Relaxed For Chinese Investment, But India Wary About Security
Rediff.com12 Mar 2026

'It's a changing world and the opening up doesn't mean that concerns with regards to...

Obesity Drug Can't Be Advertised Anymore
Rediff.com12 Mar 2026

'Any promotional activity carried out under the pretext of disease awareness,...

India Targets 200,000 Foreign Students by 2030
Rediff.com11 Mar 2026

The government has intensified its Study in India programme and is working closely with...

Govt moves to shield trade as Iran war chokes sea routes
Rediff.com5 Mar 2026

With the Iran war escalating sharply and crisis deepening in the global energy market,...

Abbott Bets On Semaglutide Boom
Rediff.com28 Feb 2026

Abbott will exclusively distribute and market Extensior in the country, becoming the...

CDSCO allows immediate lab testing of drugs to speed up approvals
Rediff.com27 Feb 2026

The Centre has allowed companies to begin lab testing immediately after filing...

Gurugram Dethrones Mumbai As India's Luxury Housing Capital
Rediff.com24 Feb 2026

Gurugram has overtaken Mumbai to become India's biggest luxury housing market in 2025,...

US Tariff Uncertainty Pauses Trade Talks
Rediff.com23 Feb 2026

'The contours of the trade deal need to be reworked now.'